FDA and Peptide Marketing Claims: What Companies Can and Cannot Say
Medically reviewed by Dr. Sarah Chen, PharmD, BCPS
A comprehensive guide to the FDA's regulations on peptide marketing. Learn what companies can and cannot say about peptide therapies, the difference between approved and unapproved peptides, and how to identify reputable suppliers.
Navigating the Regulatory Landscape: FDA and Peptide Marketing Claims
Peptide therapies have surged in popularity, offering potential benefits for a wide range of health and wellness goals. However, this rapid growth has also led to a complex and often confusing regulatory environment. The U.S. Food and Drug Administration (FDA) plays a crucial role in overseeing the manufacturing, marketing, and sale of peptides to ensure patient safety and product efficacy. Understanding the FDA peptide marketing rules is essential for both consumers and companies operating in this space. This article provides a comprehensive overview of what companies can and cannot say when marketing peptides, the different classifications of peptides, and recent FDA enforcement actions.
The Rise of Peptides and the Need for Regulation
Peptides are short chains of amino acids, the building blocks of proteins. They act as signaling molecules in the body, influencing a wide range of physiological functions. From promoting muscle growth and fat loss to improving skin health and cognitive function, the potential applications of peptides are vast. This has led to a booming market, with a growing number of companies offering peptide products directly to consumers. However, the quality, safety, and efficacy of these products can vary significantly, highlighting the critical need for robust regulatory oversight.
The FDA is responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices. This includes regulating how these products are marketed to the public. The FDA has established a comprehensive framework to govern the claims that companies can make about their products, and these regulations apply to peptides as well.
FDA's Stance on Peptides: Approved vs. Unapproved
Not all peptides are created equal in the eyes of the FDA. There are several distinct categories of peptides, each with its own set of regulations.
FDA-Approved Peptide Drugs
A small number of peptide drugs have undergone the FDA's rigorous drug approval process and have been approved to treat specific medical conditions. These drugs have been extensively studied in clinical trials to demonstrate their safety and effectiveness. Examples of FDA-approved peptide drugs include insulin for diabetes and liraglutide for weight management. Companies that manufacture and market these drugs can make specific claims about their ability to diagnose, treat, cure, or prevent a disease, as these claims are supported by robust scientific evidence. PMID: 29098012
Compounded Peptides: A Legal Gray Area
Compounded peptides are created by a pharmacist who combines or alters ingredients to create a medication tailored to the needs of an individual patient. While compounding can play an important role in medicine, compounded drugs are not FDA-approved. This means the agency does not review their safety, effectiveness, or quality before they are marketed. The FDA has expressed concerns about the quality and safety of some compounded peptides, particularly those that are mass-produced and marketed to a wide audience without individual patient prescriptions. For more information on compounded medications, you can visit our compounds page.
"Research Use Only" Peptides
Many peptides are sold online with the disclaimer "for research use only" or "not for human consumption." These products are not intended for human use and have not been evaluated by the FDA for safety or effectiveness. The FDA has warned consumers about the potential health risks associated with using these products, as they may be contaminated or contain unknown ingredients. FDA.gov
What Companies Can and Cannot Say: A Guide to Peptide Marketing Claims
The FDA has strict rules about the types of claims that can be made about peptides and other health products. These rules are designed to protect consumers from false or misleading information.
Structure/Function Claims vs. Disease Claims
The FDA distinguishes between two main types of claims: structure/function claims and disease claims. Structure/function claims describe the role of a nutrient or dietary ingredient intended to affect the normal structure or function of the human body. For example, a company could say that a peptide "supports healthy immune function." These claims do not require pre-approval from the FDA, but they must be truthful and not misleading. You can learn more about different conditions and how they can be supported by exploring our conditions page.
Disease claims, on the other hand, state that a product can diagnose, treat, cure, or prevent a disease. These claims are only permitted for FDA-approved drugs. A company cannot legally claim that a non-approved peptide can treat a specific medical condition, such as obesity or fibromyalgia.
The Dangers of Misleading Marketing
Misleading marketing claims can have serious consequences for consumers. They can lead people to delay or forgo proven medical treatments, and they can expose them to potentially harmful products. The FDA takes misleading marketing claims very seriously and has taken enforcement action against numerous companies that have violated its regulations.
| Claim Type | Permissible for Non-Approved Peptides? | Example | FDA Stance |
| :--- | :--- | :--- | :--- |
| Structure/Function Claim | Yes, if truthful and not misleading | "Supports healthy joints" | Generally permissible, but must be substantiated. |
| General Wellness Claim | Yes, if truthful and not misleading | "Promotes a sense of well-being" | Permissible, as long as it doesn't cross the line into a disease claim. |
| Disease Claim | No | "Treats arthritis" | Strictly prohibited for non-approved products. |
| Drug-Like Claim | No | "Works like a prescription drug" | Prohibited, as it implies the product is an approved drug. |
Recent FDA Enforcement Actions
The FDA has been actively cracking down on companies that make illegal marketing claims about peptides. In recent years, the agency has issued numerous warning letters to telehealth companies, compounding pharmacies, and other businesses that have violated its regulations.
Warning Letters to Telehealth Companies
In March 2026, the FDA announced that it had sent warning letters to 30 telehealth companies for making false or misleading claims about compounded GLP-1 products, such as semaglutide and tirzepatide. The FDA stated that the companies were making claims that implied their products were the same as FDA-approved drugs and were obscuring the source of the products. [1]
---
The specialists at TeleGenix can help you navigate the complexities of peptide therapy and find a treatment plan that is right for you.
---
How to Identify Reputable Peptide Suppliers
With so many companies selling peptides online, it can be difficult to know who to trust. Here are some red flags to watch out for:
Making illegal disease claims: As discussed above, companies cannot legally claim that non-approved peptides can treat specific medical conditions.
Lack of transparency: Reputable suppliers will be transparent about their manufacturing processes, quality control procedures, and the source of their products.
No prescription required: Peptides that are intended for human use should only be dispensed by a licensed pharmacy pursuant to a valid prescription from a qualified healthcare provider.
When choosing a peptide provider, it is important to do your research and choose a company that is committed to quality, safety, and transparency. Our peptide therapy guide can provide you with more information on how to choose a reputable supplier. For those interested in testosterone replacement therapy, our testosterone library offers a wealth of information.
The Future of Peptide Regulation
The regulatory landscape for peptides is constantly evolving. The FDA is continuing to monitor the market and take action against companies that violate its regulations. There is also an ongoing debate about the appropriate level of regulation for peptides, with some arguing for stricter controls and others advocating for greater access.
It is likely that we will see further developments in peptide regulation in the coming years. As the science of peptides continues to advance, the FDA will need to adapt its regulatory framework to ensure that it is keeping pace with the latest developments. For a comparison of different peptide therapies, you can visit our compare page. Our extensive library also contains a wide range of articles on peptides and other health topics.
Conclusion
The world of peptide therapy offers exciting possibilities, but it's crucial to approach it with caution and a clear understanding of the regulatory landscape. The FDA's rules are in place to protect consumers from fraudulent claims and potentially unsafe products. By understanding the difference between approved and unapproved peptides, recognizing misleading marketing tactics, and choosing reputable suppliers, you can make informed decisions about your health and wellness. Always consult with a qualified healthcare provider before starting any new treatment, including peptide therapy. For those seeking TRT, you can find a clinic near you with our TRT near me tool.
References
Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any treatment.*
The Importance of Physician Consultation
Given the complexities of peptide therapy and the potential for adverse effects, consulting with a qualified healthcare provider is paramount. A physician can assess your individual health needs, determine if peptide therapy is appropriate for you, and recommend a safe and effective treatment plan. They can also help you navigate the regulatory landscape and identify reputable sources for peptides. Self-prescribing and sourcing peptides from unregulated online vendors can be dangerous and may lead to serious health consequences. The specialists at TeleGenix can provide expert guidance and personalized treatment plans.
The Evolving Regulatory Landscape
The FDA's approach to peptide regulation is continually evolving as new research emerges and the market landscape shifts. The agency's recent actions against telehealth companies and its ongoing evaluation of compounded peptides signal a move towards greater scrutiny and enforcement. It is anticipated that the FDA will continue to refine its guidance on peptide products to better protect public health. This may include stricter controls on the manufacturing and marketing of certain peptides, as well as enhanced surveillance of the online marketplace. As the science behind peptide therapies advances, the regulatory framework will need to adapt to ensure that patients have access to safe and effective treatments while being protected from fraudulent claims and substandard products. PMID: 33357399
---